These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 11931378)

  • 61. [Current data on the counting of weak leukocyte concentrations in labile blood products].
    Masse M
    Transfus Clin Biol; 1995; 2(5):365-72. PubMed ID: 8581179
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The mechanism of white cell reduction by synthetic fiber cell filters.
    Callaerts AJ; Gielis ML; Sprengers ED; Muylle L
    Transfusion; 1993 Feb; 33(2):134-8. PubMed ID: 8430452
    [TBL] [Abstract][Full Text] [Related]  

  • 63. 10(6) Depletion of WBC with CF-2, a new leukocyte removal filter.
    Endo Y; Tani T; Yokota T; Tsutamoto Y; Kodama M
    Am J Hematol; 1993 Sep; 44(1):38-41. PubMed ID: 8342563
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Flow cytometric analysis of residual white blood cell concentration and platelet activation antigens in double filtered platelet concentrates.
    Lombardo JF; Cusack NA; Rajagopalan C; Sangaline RJ; Ambruso DR
    J Lab Clin Med; 1993 Nov; 122(5):557-66. PubMed ID: 8228574
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Filtration technology].
    Hellot C
    Rev Fr Transfus Hemobiol; 1993 Jun; 36(3):223-42. PubMed ID: 8347248
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Evaluation of a whole-blood WBC-reduction filter that saves platelets: in vitro studies.
    Larsson S; Gulliksson H; Paunovic D
    Transfusion; 2001 Apr; 41(4):534-9. PubMed ID: 11316906
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Comparative evaluation of 3 leukocyte filters for thrombocyte concentrates].
    Reiser M; Kádár JG; Borberg H
    Beitr Infusionsther; 1991; 28():216-9. PubMed ID: 1725623
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Improved platelet compatiblity of water vapour glow discharge treated non-woven poly(ethylene terephthalate) leukocyte-reduction filters for different types of platelet concentrates.
    Kostelijk EH; Klomp AJ; Engbers GH; Gouwerok CW; Verhoeven AJ; van Aken WG; Feijen J; de Korte D
    Transfus Med; 2001 Jun; 11(3):199-205. PubMed ID: 11422950
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The in vitro evaluation of two filters (Erypur and Imugard IG 500) for white cell-poor platelet concentrates.
    Brubaker DB; Romine CM
    Transfusion; 1988; 28(4):383-5. PubMed ID: 3388485
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Demonstration by flow cytometry of the numbers of residual white blood cells and platelets in filtered red blood cell concentrates and plasma preparations.
    Neumüller J; Schwartz DW; Mayr WR
    Vox Sang; 1997; 73(4):220-9. PubMed ID: 9407639
    [TBL] [Abstract][Full Text] [Related]  

  • 71. White cells in fresh-frozen plasma: evaluation of a new white cell-reduction filter.
    Willis JI; Lown JA; Simpson MC; Erber WN
    Transfusion; 1998 Jul; 38(7):645-9. PubMed ID: 9683102
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Value of central analysis of leucocyte depletion quality control data within the National Blood Service, England.
    Beckman N; Cardigan R; Wallington T; Williamson LM
    Vox Sang; 2002 Aug; 83(2):110-8. PubMed ID: 12201840
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Removal by white cell-reduction filters of activated platelets expressing CD62.
    Pedigo M; Wun T; Paglieroni T
    Transfusion; 1993; 33(11):930-5. PubMed ID: 7505067
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The effect of whole-blood storage time on the number of white cells and platelets in whole blood and in white cell-reduced red cells.
    van der Meer PF; de Wildt-Eggen J
    Transfusion; 2006 Apr; 46(4):589-94. PubMed ID: 16584435
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Quality control of leucocyte-reduced blood components: overestimation of WBC content due to nucleated red blood cells.
    Fischer JC; Moog R; Giers G
    Vox Sang; 2012 Jan; 102(1):79-81. PubMed ID: 21564108
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Evaluating leucodepletion systems suitable for routine use.
    Rowe G
    Transfus Sci; 2000; 22(1-2):61-2. PubMed ID: 10771384
    [No Abstract]   [Full Text] [Related]  

  • 77. Bacteria-induced release of white cell--and platelet-derived vascular endothelial growth factor in vitro.
    Nielsen HJ; Werther K; Mynster T; Svendsen MN; Rosendahl S; Elley T; Skov F
    Vox Sang; 2001 Apr; 80(3):170-8. PubMed ID: 11449957
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Comparison of four filters for leukocyte depletion of single donor plateletapheresis products.
    Sintnicolaas K; van Putten WL
    Transfus Sci; 1993 Apr; 14(2):211-5. PubMed ID: 10148614
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Quality assurance by a commercial flow cytometry method of leucodepletion of whole blood donations: initial application of universal testing and proposals for a batch-release sampling plan.
    Barclay GR; Walker B; Gibson J; McColl K; Turner ML
    Transfus Med; 2000 Mar; 10(1):37-48. PubMed ID: 10760202
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Preparation of leukocyte-poor platelets by filtration.
    Sniecinski I; Jean JS; Nowicki B
    J Clin Apher; 1989; 5(1):7-11. PubMed ID: 2777739
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.